ArticleCancer biology & therapy2015

Strigolactone analogs act as new anti-cancer agents in inhibition of breast cancer in xenograft model.

Einav Mayzlish-Gati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.